Corium International Transdermal Patch Technology - PowerPoint PPT Presentation

1 / 27
About This Presentation
Title:

Corium International Transdermal Patch Technology

Description:

Corium International Transdermal Patch Technology Corium International 4558 50th Street Grand Rapids, MI 49512 616.656.4563 Presentation Outline Personal Bio s ... – PowerPoint PPT presentation

Number of Views:1005
Avg rating:3.0/5.0
Slides: 28
Provided by: egrMsuEd7
Category:

less

Transcript and Presenter's Notes

Title: Corium International Transdermal Patch Technology


1
Corium InternationalTransdermal Patch Technology
  • Corium International
  • 4558 50th Street
  • Grand Rapids, MI 49512
  • 616.656.4563

2
Presentation Outline
  • Personal Bios
  • Corium Capabilities
  • Corium Transdermal/Transmucosal Technology
  • Transdermal Functional Requirements
  • Anatomy of the Skin
  • Transdermal Patch Mfg Process Flow
  • Transdermal Patch Unit Operations
  • Mix/Coat Processes
  • Lamination and Die Cut Processes
  • Fill and Seal Processes
  • Pouching Process

3
Personal Bios
  • Steve Klemm Chief Operating Officer
  • Bachelor of Science in Chemical Engineering,
    Michigan State University
  • Plant Manager, Director of Global Engineering and
    RD for Amway, General Manager for Central States
    Precision
  • Holds 3 patents for specialized delivery systems,
    included delayed release
  • Developed proprietary extraction, dehydration,
    emulsion process technologies
  • Dan Arsulowicz, Director of Project Mgmt
    Process Development
  • Bachelor of Science, Chemical Engineering,
    University of Michigan
  • Masters in Business Administration, Grand Valley
    State University
  • 8 years in Process Development and Manufacturing
    of cosmetic, OTC, medical device, and Rx liquid
    dose, solid state, and transdermal products.

4
Corium International, Inc.
A World-Class Drug Delivery Company that Develops
Pharmaceutical Products for Delivery Through the
Skin Mucosa
5
Coriums Capabilities
Concept / Project Planning
Clinical Supply Studies
Commercial Manufacture Launch
Feasibility Development Studies
Mfg Process Development Scale-Up
Continuous Supply Process Improvement
  • Depth of RD experience
  • Breadth of manufacturing capabilities
  • Novelty and flexibility of drug delivery platforms

6
Diverse Experience with Commercial Product
Development and Manufacturing
  • Transdermal Drug Delivery Systems
  • First Nitroglycerin (Nitro-dur)
  • First OTC Nicotine (Nicotrol)
  • 7-day Estradiol (Fempatch)
  • Fentanyl (through Phase III)
  • First (and only) Scopolamine and Clonidine
  • First Contraceptive (Evra)
  • OTC Dermal Delivery Systems
  • Wart, Corn and Callus Treatment
  • Pain, Poison Ivy and First Aid
  • Teeth Whitening
  • Medical Device and Diagnostics
  • ECK/EKG Monitoring and Diagnostic
  • Transcutaneous Electrical Nerve Neuromuscular
    Stimulation
  • Electro-Surgical Grounding Pads
  • Fecal Occult Blood Test
  • Non-Invasive Glucose Monitoring
  • Wound Care Products
  • Transparent Film Dressings
  • Chronic Wound Treatment
  • Wound Closure Strips

7
(No Transcript)
8
Development Commercial Programs
9
Manufacturing RD
Manufacturing Grand Rapids, Michigan
  • 160,000 sq ft GMP, DEA, ISO qualified facilities
  • Process development and scale-up
  • Pilot/Clinical Commercial manufacturing
  • In-line labeling, packaging cartoning
  • Complete Analytical Testing Capabilities

Research Development Redwood City, CA
  • Formulation and product development
  • Small-scale prototyping

Basic Applied Research Moscow, Russia
  • Research and new technology development at the
    Russian Academy of Sciences

10
Custom Designed Transdermal / Mucosal Systems
Rapid Onset
25
Intermittent 1
20
Intermittent 2
Continuous Release
15
Blood Level Activity
10
5
0
0
5
12
22
Time
11
Corium Transdermal Delivery Systems
Solid State Film System side view
Also applies to Dermal, Mucosal and
Transmucosal Delivery
12
Corium Transdermal Delivery Systems
Backing
Drug reservoir
Adhesive
Release liner
Specialized Membrane
Specialized Membrane
Liquid Reservoir System
side view
Also applies to Dermal, Mucosal and
Transmucosal Delivery
13
Micro-Delivery Systems
  • Minimally invasive micro-delivery array or heat
    element for trans-epidermal delivery of
    pharmaceutical product
  • High degree of flexibility in depth of delivery
    20 200 µm stratum corneum through to dermis

Stratum Corneum
Viable Epidermis
Dermis
Nerve Endings Blood Vessels
14
Basic Functional Requirements
  • Adhesion to Skin
  • Initial Tack
  • Wear Duration
  • Overlay Options
  • Delivery of Drug Active
  • Assay, Impurity
  • Controlled Release Drug Delivery Rate
  • Removal from Skin
  • Minimal irritation and force

15
Anatomy of the Skin
16
Transdermal System Unit Operations Requirements
17
Transdermal Systems Scale-Up and Manufacturing
Options Mix Process
  • Mix Technology
  • Scrapewall
  • Used for low shear, gentle mixing and to
    facilitate heat transfer
  • Disperser
  • High Shear mixing technology to facilitate
    material dispersion
  • Homogenizer
  • High shear mixing technology to control particle
    size (e.g. improve API particle size uniformity)

18
Transdermal SystemsCritical Control PointsMix
Process
  • Mix Process
  • Typical Critical Process Parameters
  • Agitation Speeds
  • Agitation Times
  • Mix Temperatures
  • Typical Response Variables
  • Blend Appearance
  • Blend Drug/Enhancer Assay
  • Blend Viscosity
  • Particle size

19
Transdermal Systems Scale-Up and Manufacturing
Options Coating Process
  • Coating Scale
  • Lab Scale Batch Coating
  • Pilot/Production Scale Continuous Coating
  • Application Technology
  • Comma Coating
  • Knife Over Roll Coating
  • Slot Die Coating
  • Drying Technology
  • Impingement Drying
  • Flotation Drying
  • Drying Capacity
  • Single-Zone
  • Multi-Zone Drying

20
Transdermal SystemsCritical Control
PointsCoating Process
  • Coating Process
  • Typical Critical Process Parameters
  • Coating Technology
  • Dryer Temperature
  • Dryer Air Flow
  • Coating Line Speed
  • Typical Response Variables
  • Residual Solvent
  • Coat Weight
  • Drug/Enhancer Assay

21
Transdermal SystemsSample Coating Line Equipment
Layout
22
Transdermal SystemsCritical Control
PointsLamination and Die Cut Process
  • Lamination and Die Cut Process
  • Process Options
  • Individual Die Cut Parts
  • Die Cut into Reels
  • Typical Critical Process Parameters
  • Die condition
  • Web Tension
  • Lamination Pressure
  • Typical Response Variables
  • Part Size and Shape
  • Drug/Enhancer Assay
  • Drug Release Rate

23
Transdermal SystemsSample Die Cut and Lamination
Equipment Layout
24
Transdermal SystemsCritical Control PointsFill
and Seal Processes
  • Fill and Seal Processes
  • Typical Critical Process Parameters
  • Fill Volume, placement
  • Seal Time, Temperature, Pressure
  • Typical Response Variables
  • Fill Weight
  • Drug/Enhancer Assay
  • Seal Integrity
  • Drug Release Rate

25
Transdermal SystemsCritical Control
PointsPouching Process
  • Pouching Process
  • Process Options
  • Reel Feed Via Cross Feed Station
  • Pick and Place
  • Typical Critical Process Parameters
  • Sealing Time
  • Sealing Temperature
  • Sealing Pressure
  • Typical Response Variables
  • Pouch Seal Integrity
  • Pouch Burst Strength

26
Transdermal SystemsSample Pouching Equipment
Layout
27
QUESTIONS??THANK YOU!!
Write a Comment
User Comments (0)
About PowerShow.com